As manager of the firm's global relationship with client GlaxoSmithKline LLC, Weissman was on the firing line when 52 plaintiffs born in the 1950s or early 1960s sued over claims their birth defects were caused by Thalidomide, a drug used in clinical trials by predecessor Smith Kline & French until its dangers were understood.
"It's been a really interesting engagement, with really sympathetic plaintiffs suffering unusual and severe birth defects...
To continue reading, please subscribe.
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In